Clinical Trials Logo

Congenital Abnormalities clinical trials

View clinical trials related to Congenital Abnormalities.

Filter by:

NCT ID: NCT03847064 Completed - Deformity; Bone Clinical Trials

Correction of Lower Limb Deformities With Fixator Assisted Nailing

Start date: January 1, 2010
Phase:
Study type: Observational

It is a retrospective study at a tertiary care hospital. All cases of lower limb deformity whose correction was done with fixator assisted IM nailing from 2010 till 2017 were analyzed.

NCT ID: NCT03831035 Completed - Intensive Care Unit Clinical Trials

Fast Exome for Diagnosis of Congenital Conditions in Infants Under 12 Months of Age Hospitalized in Intensive Care Unit

REUNIR
Start date: April 8, 2019
Phase:
Study type: Observational

An early diagnosis of congenital malformations and suspected genetic conditions in critically ill infants is essential to perform specific adapted care, prevention, and give proper genetic counseling. However, etiologies are various and each of them is individually very rare. Thanks to next-generation sequencing technologies, diagnosis time frames have drastically decreased and the investigators have observed an increase in diagnosis yields. This study aims to evaluate the feasibility of fast trio exome sequencing (less than 16 days between informed consent signature and the consultation for results to the parents) in infants under the age of 12 months hospitalized in Intensive Care Unit (ICU).

NCT ID: NCT03828942 Completed - Hematotoxicity Clinical Trials

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

HeMATOX
Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

Several drugs and chemotherapies seem to have an impact on the hematological system. This study investigates reports of hematological toxicities, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

NCT ID: NCT03816423 Completed - Aneuploidy Clinical Trials

Use of Videos to Improve Patient Knowledge on Prenatal Genetics

VPE
Start date: May 30, 2019
Phase: N/A
Study type: Interventional

This is a randomized controlled trial of a low income and low health literacy population of pregnant women from a diverse racial and ethnic background to assess the effectiveness of a pre-visit educational video on prenatal genetic screening and testing options.

NCT ID: NCT03800615 Completed - Clinical trials for Stress Urinary Incontinence

Iatrogenic Impairment of Urethral Coitus Owing to Midurethral Sling Procedure in a Woman With Vaginal Agenesis.

Start date: January 9, 2019
Phase:
Study type: Observational

To report a case of impairment urethral coitus after the midurethral sling procedure

NCT ID: NCT03799705 Completed - Clinical trials for Congenital Malformation

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway

Start date: December 1, 2019
Phase:
Study type: Observational

Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.

NCT ID: NCT03795857 Completed - Fetal Anomaly Clinical Trials

Antenatal Palliative Care

SPAN
Start date: January 14, 2019
Phase:
Study type: Observational

In France, according to current legislation, termination of pregnancy could be performed without any upper gestational age limit, if there is a strong probability that the fetus will be affected by a particularly severe and incurable disease. When there is a lethal fetal diagnosis most of parents wish to terminate their pregnancy. However, and despite some medical resistance a few of them do wish to continue pregnancy. In these situations, palliative care seems to be a good way to prepare to welcome the child and surround him until death. The aim of the study is to describe parents' experience for a better understanding and a better care.

NCT ID: NCT03746834 Completed - Fecal Incontinence Clinical Trials

NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation

Start date: September 20, 2013
Phase: Phase 4
Study type: Interventional

Persistent fecal incontinence (FI) after anorectal malformations (ARM) is a common occurence. During the last two decades perianal injection therapy has emerged as an option for treating patients with FI due to other causes than ARMs. The studies done on different implants have always expempted patients with ARM which has led to ARM being a formal contraindication for treatment with perianal injection therapy. The study aims to treat patients with persistent FI after ARM with perianal injection of NASHA/Dx (Solesta®) and follow them with Clinical examination and questionnaires up to 18 months post treatment.

NCT ID: NCT03740997 Completed - Clinical trials for Transthoracic Echocardiography

Study to Determine Safety and Dosage of OPTISON in Pediatric Participants

Start date: December 1, 2020
Phase: Phase 4
Study type: Interventional

Study to determine the safety and appropriate dosage of OPTISON in pediatric participants since OPTISON has been tested in adult participants only during the clinical development

NCT ID: NCT03727230 Completed - Blood Transfusion Clinical Trials

RhD+ Blood Transfusion to Asian-type DEL Recipients

Start date: October 1, 2016
Phase: N/A
Study type: Interventional

Red blood cells (RBCs) from Asian-type DEL blood group express very weak RhD antigen and are falsely typed as RhD-negative blood group in routine RhD testing. Until now, Asian-type DEL (D-eluate) patients still be treated as rare RhD-negative patients in the clinic. Previous study from the Asian-type DEL pregnant women with RhD+ fetus showed no occurrence of alloanti-D immunization. This result, however, does not directly be applied for Asian-type DEL patients receiving RhD+ blood transfusions, as lacking of direct evidence regarding the safety and underlying mechanism. In this study, the patients with Asian-type DEL were identified and received RhD+ blood transfusion, then evaluations of any adverse reactions, especially the active follow-up alloantibody test, were prospectively conducted.